Bandingkan Harga & Kinerja Elnusa Tbk. (ELSA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Elnusa Tbk. dan Organon Pharma Indonesia Tbk.: Elnusa Tbk. diperdagangkan di Rp725 (kapitalisasi pasar 5,33 T, volume 24 jam 33,14 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Elnusa Tbk. jauh lebih besar — sekitar 51,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| ELSA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 5,33 T | 104,4 M |
Volume | 33,14 jt | — |
Lot | 331,38 rb | — |
Perputaran | 24,44 M | — |
Harga Rata-rata | 737,47 | — |
Nilai Transaksi | 24,44 M | — |
Harga Ekuilibrium Indikatif | 725 | — |
Volume Ekuilibrium Indikatif | 24,27 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Elnusa Tbk.
PT Elnusa Tbk (Company) was established under the name of PT Elektronika Nusantara on January 25, 1969 based on notarial deed No.18 of Tan Thong Kie, S.H., dated January 25, 1969, as amended by notarial deed No. 10 of the same notary dated February 13, 1969. The Company’s articles of association has been amended several times, most recently by notarial deed No. 2 of Soegeng Santosa, S.H., dated Jan 7, 2002, concerning among others, the change in the Company’s name and public offering.
Selengkapnya di halaman ELSA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
